Herbert G Sayer Selected Research

Herbert G Sayer Research Topics

Disease

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2022 - 06/2005
4	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2017 - 12/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014 - 07/2003
3	Myocardial Infarction 07/2005 - 10/2004
2	Mycoses (Diseases, Fungus) 06/2022 - 01/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021 - 09/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2021 - 09/2014
2	Infections 03/2017 - 04/2016
2	Multiple Myeloma 03/2017 - 06/2004
2	Fever (Fevers) 12/2016 - 04/2016
2	Bronchiolitis Obliterans Syndrome 08/2013 - 07/2003
2	Breast Neoplasms (Breast Cancer) 06/2003 - 01/2002
1	Sepsis (Septicemia) 06/2022
1	Stomatitis 01/2018
1	Pure Red-Cell Aplasia 03/2017
1	Bacteremia 04/2016
1	Febrile Neutropenia 04/2016
1	Posterior Leukoencephalopathy Syndrome 01/2016
1	Bone Marrow Failure Disorders 09/2014
1	Inflammation (Inflammations) 09/2014
1	Lymphoma (Lymphomas) 09/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014
1	Systemic Scleroderma (Systemic Sclerosis) 08/2013
1	Fusariosis 11/2008
1	Philadelphia Chromosome 01/2006
1	Body Weight (Weight, Body) 07/2005
1	Residual Neoplasm 05/2005
1	Cardiomyopathies (Cardiomyopathy) 04/2005
1	Infarction (Infarctions) 04/2005
1	Heart Failure 04/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2005
1	13q deletion syndrome 06/2004
1	Neoplasms (Cancer) 06/2003
1	Long Term Adverse Effects 01/2002

Drug/Important Bio-Agent (IBA)

2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2017 - 06/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2016 - 06/2003
2	Pharmaceutical PreparationsIBA 08/2014 - 01/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2022
1	Fibroblast Growth Factor 7 FDA Link 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 03/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2017
1	SteroidsIBA 03/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2017
1	Tyrosine Kinase InhibitorsIBA 02/2017
1	Phosphatidylcholines (Phosphatidylcholine)IBA 04/2016
1	ProcalcitoninIBA 04/2016
1	C-Reactive ProteinIBA 04/2016
1	Peptides (Polypeptides)IBA 04/2016
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	ProteomeIBA 04/2016
1	galactomannanIBA 01/2016
1	Calcineurin InhibitorsIBA 01/2016
1	Rituximab (Mabthera)FDA Link 09/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2014
1	fludarabineIBA 09/2014
1	treosulfanIBA 09/2014
1	Azacitidine (5 Azacytidine)FDA Link 09/2014
1	AntibodiesIBA 08/2013
1	Platelet-Derived Growth FactorIBA 08/2013
1	AutoantibodiesIBA 08/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2006
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2005
1	Interleukin-18 (Interleukin 18)IBA 12/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2003
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2003
1	Estrogens (Estrogen)FDA Link 01/2002
1	Tamoxifen FDA LinkGeneric 01/2002
1	Hormones (Hormone)IBA 01/2002
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2002

Therapy/Procedure

9	Stem Cell Transplantation 06/2022 - 07/2003
6	Drug Therapy (Chemotherapy) 09/2022 - 01/2002
5	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2013 - 06/2003
4	Hematopoietic Stem Cell Transplantation 01/2018 - 08/2012
4	Therapeutics 03/2017 - 01/2002
2	Induction Chemotherapy 06/2022 - 06/2003
2	Stents 07/2005 - 10/2004
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2005 - 10/2004
2	Catheters 04/2005 - 10/2004
2	Transplantation 04/2005 - 10/2004
1	Critical Care (Surgical Intensive Care) 06/2022
1	Immunomodulation 09/2014
1	Lasers (Laser) 11/2008
1	Cell Transplantation 01/2006
1	Duration of Therapy 07/2005
1	Homologous Transplantation 06/2004
1	Castration 01/2002